Cas no 124529-07-3 (D-Cysteine,N-(2-methyl-1-oxopropyl)-)
D-Cysteine,N-(2-methyl-1-oxopropyl)- Chemical and Physical Properties
Names and Identifiers
-
- D-Cysteine,N-(2-methyl-1-oxopropyl)-
- N-ISOBUTYRYL-D-CYSTEINE
- N-(2-methylpropanoyl)-D-cysteine
- I-BUT-D-CYS-OH
- ISOBUTYRYL-D-CYS-OH
- ISOBUTYRYL-D-CYSTEINE
- N-(2-METHYLPROPIONYL)-D-CYSTEINE
- N-ISOBUTYRYL-D-CYSTEINE FLUKABRAND &
- BWBQXMAXLAHHTK-RXMQYKEDSA-N
- N-(2-Methylpropionyl)-D-cysteine;
- J-005091
- (2S)-2-(2-methylpropanoylamino)-3-sulfanylpropanoic acid
- 124529-07-3
- N-isobutyryl-d-cys
- DTXSID00357425
- D-Cysteine, N-(2-methyl-1-oxopropyl)-
- N-Isobutyryl-D-cysteine, for chiral derivatization, >=97.0%
- SCHEMBL3014643
-
- MDL: MFCD00155641
- Inchi: 1S/C7H13NO3S/c1-4(2)6(9)8-5(3-12)7(10)11/h4-5,12H,3H2,1-2H3,(H,8,9)(H,10,11)/t5-/m1/s1
- InChI Key: BWBQXMAXLAHHTK-RXMQYKEDSA-N
- SMILES: SC[C@H](C(=O)O)NC(C(C)C)=O
Computed Properties
- Exact Mass: 191.06169
- Monoisotopic Mass: 191.06161445g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 2
- Hydrogen Bond Acceptor Count: 3
- Heavy Atom Count: 12
- Rotatable Bond Count: 4
- Complexity: 182
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 1
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Surface Charge: 0
- Tautomer Count: 2
- XLogP3: 0.5
- Topological Polar Surface Area: 66.4
Experimental Properties
- Color/Form: crystal
- Melting Point: 97-101?°C (lit.)
97-101?°C - PSA: 66.4
- Solubility: Not determined
D-Cysteine,N-(2-methyl-1-oxopropyl)- Security Information
- Hazardous Material transportation number:NONH for all modes of transport
- WGK Germany:3
- Safety Instruction: 22-24/25
- FLUKA BRAND F CODES:3-10-23
- Storage Condition:2-8°C
D-Cysteine,N-(2-methyl-1-oxopropyl)- Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| SHANG HAI JI ZHI SHENG HUA Technology Co., Ltd. | SA03174-250mg |
D-Cysteine,N-(2-methyl-1-oxopropyl)- |
124529-07-3 | 250mg |
¥1338.0 | 2021-09-04 | ||
| SHENG KE LU SI SHENG WU JI SHU | sc-236051-250 mg |
N-Isobutyryl-D-cysteine, |
124529-07-3 | ≥97% | 250MG |
¥2,174.00 | 2023-07-10 | |
| SHENG KE LU SI SHENG WU JI SHU | sc-236051-250mg |
N-Isobutyryl-D-cysteine, |
124529-07-3 | ≥97% | 250mg |
¥2174.00 | 2023-09-05 |
D-Cysteine,N-(2-methyl-1-oxopropyl)- Related Literature
-
Wei Ma,Changlong Hao,Maozhong Sun,Liguang Xu,Chuanlai Xu,Hua Kuang Mater. Horiz. 2018 5 141
-
Hua-Ming Xiao,Xian Wang,Quan-Lan Liao,Shuai Zhao,Wei-Hua Huang,Yu-Qi Feng Analyst 2019 144 6578
-
3. Stereochemical effects of chiral monolayers on enhancing the resistance to mammalian cell adhesionDebjyoti Bandyopadhyay,Deepali Prashar,Yan-Yeung Luk Chem. Commun. 2011 47 6165
-
Arafeh Bigdeli,Forough Ghasemi,Nafiseh Fahimi-Kashani,Samira Abbasi-Moayed,Afsaneh Orouji,Zahra Jafar-Nezhad Ivrigh,Faezeh Shahdost-Fard,M. Reza Hormozi-Nezhad Analyst 2020 145 6416
-
Cecilia Noguez,Ignacio L. Garzón Chem. Soc. Rev. 2009 38 757
Additional information on D-Cysteine,N-(2-methyl-1-oxopropyl)-
D-Cysteine, N-(2-methyl-1-oxopropyl)-: A Comprehensive Overview
The compound with CAS No. 124529-07-3, commonly referred to as D-Cysteine, N-(2-methyl-1-oxopropyl)-, is a significant molecule in the field of chemistry and biochemistry. This compound is a derivative of D-cysteine, a naturally occurring amino acid, and its structure incorporates a N-(2-methyl-1-oxopropyl) group, which adds unique functional properties to the molecule. The compound has garnered attention in recent years due to its potential applications in drug development, nutraceuticals, and biotechnology.
D-Cysteine is one of the two enantiomers of cysteine, the other being L-cysteine. While L-cysteine is more commonly found in biological systems, D-cysteine has distinct properties that make it valuable for specific applications. The N-(2-methyl-1-oxopropyl) group attached to the nitrogen atom introduces a ketone functionality, which can participate in various chemical reactions. This modification enhances the compound's stability and bioavailability, making it a promising candidate for therapeutic agents.
Recent studies have explored the role of D-Cysteine, N-(2-methyl-1-oxopropyl)- in antioxidant defense mechanisms. Cysteine derivatives are known for their ability to scavenge reactive oxygen species (ROS), which are implicated in various diseases such as cancer, neurodegenerative disorders, and cardiovascular diseases. The addition of the N-(2-methyl-1-oxopropyl) group has been shown to enhance the molecule's ability to neutralize ROS more effectively than unmodified D-cysteine. This makes it a potential candidate for developing novel antioxidant therapies.
In the field of nutraceuticals, D-Cysteine, N-(2-methyl-1-oxopropyl)- has been investigated for its role in boosting glutathione levels in the body. Glutathione is a critical antioxidant that plays a vital role in detoxification and immune function. By incorporating this compound into dietary supplements, researchers aim to provide individuals with an enhanced defense against oxidative stress without the side effects associated with synthetic antioxidants.
The synthesis of D-Cysteine, N-(2-methyl-1-oxopropyl)- involves a multi-step process that includes amino acid modification and functional group transformations. Recent advancements in asymmetric synthesis have enabled the production of this compound with high enantiomeric purity, which is essential for its application in pharmaceuticals. The use of green chemistry principles in its synthesis has also been explored to minimize environmental impact.
Another area of interest is the use of D-Cysteine, N-(2-methyl-1-oxopropyl)- as a building block for peptide synthesis. Its unique structure allows for the creation of peptides with tailored biological activities. Researchers have reported that peptides incorporating this derivative exhibit improved stability and bioavailability compared to those made from unmodified cysteine.
From a structural standpoint, D-Cysteine differs from L-cysteine in the configuration of its chiral center. The addition of the N-(2-methyl-1-oxopropyl) group further modifies its stereochemistry, influencing its interactions with biological systems. Computational studies have provided insights into how these modifications affect the molecule's pharmacokinetics and pharmacodynamics.
In conclusion, D-Cysteine, N-(2-methyl-1-oxopropyl)- (CAS No. 124529-07-3) is a versatile compound with promising applications across multiple fields. Its unique chemical structure and functional properties make it an attractive candidate for drug development, nutraceuticals, and biotechnology. As research continues to uncover new insights into its potential uses, this compound is poised to play an increasingly important role in advancing human health and well-being.
124529-07-3 (D-Cysteine,N-(2-methyl-1-oxopropyl)-) Related Products
- 124529-02-8(L-Cysteine,N-(2-methyl-1-oxopropyl)-)
- 2885-79-2(N-Propionyl-L-cysteine)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)